| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Mouse OX40/TNFRSF4 Fc Chimera Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 65-75 kDa, reducing conditions. MW (theoretical): 48 kDa (monomer). The Recombinant Mouse OX40/TNFRSF4 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Mouse OX40/TNFRSF4 Fc Chimera Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | ACT-135, ACT35 antigen, ACT35ATC35 antigen, CD134, CD134 antigen, Ly-70, OX40 cell surface antigen, OX40 homologue, OX40L receptor, OX40lymphoid activation antigene ACT35, TAX transcriptionally-activated glycoprotein 1 receptor, tax-transcriptionally activated glycoprotein 1 receptor, TNFRSF4, tumor necrosis factor receptor superfamily member 4, tumor necrosis factor receptor superfamily, member 4, Txgp1, TXGP1L, TXGP1LOX40 antigen |
|---|
| Gene, Accession, CAS # | Tnfrsf4, Gene ID: 22163, Accession: P47741 |
|---|
| Catalog # | 1256-OX-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Mouse OX40/TNFRSF4 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 18635004, 30590049 |
|---|
| 产品资料 |
|
|